This enhanced capacity will also help the company to increase its global presence in various geographies and achieve leadership position in the global merchant markets. In the domestic market it further strengthens and consolidates its position as a market leader.

With this additional capacity, Jubilant Ingrevia also provides opportunity to its global customers to further expand their downstream products across end‐user industries viz. Pharmaceuticals, Agrochemicals, Food, Vitamins, Wood Acetylation, Electronics, Dyes industry etc.

Rajesh Srivastava, chief executive officer (CEO) & managing director, Jubilant Ingrevia, said, “We are pleased with the commissioning of our new global scale acetic anhydride plant. This additional capacity of acetic anhydride will further ensure sufficient feedstock availability for our various global customers for their end products, as well as help them achieve their desired growth across global markets.”

Jubilant Ingrevia is a global integrated life science products and innovative solutions provider serving, pharmaceutical, nutrition, agrochemical, consumer and industrial customers with its customised products and solutions that are innovative, cost effective and conforming to premium quality standards. The company is engaged in manufacturing and supply of speciality chemicals, nutrition & health solutions and chemical intermediates through five manufacturing facilities in India.

On consolidated basis, Jubilant Ingrevia's net profit tumbled 29% to Rs 92 crore on 10.16% decline in revenue from operations to Rs 1,152.63 crore in Q3 FY23 over Q3 FY22.

The scrip rose 0.85% to Rs 402 on the BSE.